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Periostin loss-of-function protects mice from
post-traumatic and age-related osteoarthritis
Mukundan Attur1*†, Xin Duan2†, Lei Cai2, Tianzhen Han1,3, Weili Zhang2, Eric D. Tycksen4, Jonathan Samuels1,
Robert H. Brophy2, Steven B. Abramson1 and Muhammad Farooq Rai2,5*

Abstract
Background: Elevated levels of periostin (Postn) in the cartilage and bone are associated with osteoarthritis (OA).
However, it remains unknown whether Postn loss-of-function can delay or prevent the development of OA. In this
study, we sought to better understand the role of Postn in OA development and assessed the functional impact of
Postn deficiency on post-traumatic and age-related OA in mice.
Methods: The effects of Postn deficiency were studied in two murine experimental OA models using Postn−/− (n =
32) and littermate wild-type (wt) mice (n = 36). Post-traumatic OA was induced by destabilization of the medial
meniscus (DMM) in 10-week-old mice (n = 20); age-related OA was analyzed in 24-month-old mice (n = 13).
Cartilage degeneration was assessed histologically using the OARSI scoring system, and synovitis was evaluated by
measuring the synovial lining cell layer and the cells density in the synovial stroma. Bone changes were measured
by μCT analysis. Serum levels of Postn were determined by ELISA. Expression of Postn and collagenase-3 (MMP-13)
was measured by immunostaining. RNA-seq was performed on chondrocytes isolated from 21-day old Postn−/−
(n = 3) and wt mice (n = 3) to discover genes and pathways altered by Postn knockout.
Results: Postn−/− mice exhibited significantly reduced cartilage degeneration and OARSI score relative to wt mice in
post-traumatic OA after 8 weeks (maximum: 2.37 ± 0.74 vs. 4.00 ± 1.20, P = 0.011; summed: 9.31 ± 2.52 vs. 21.44 ±
6.01, P = 0.0002) and spontaneous OA (maximum: 1.93 ± 0.45 vs. 3.58 ± 1.16, P = 0.014; summed: 6.14 ± 1.57 vs.
11.50 ± 3.02, P = 0.003). Synovitis was significantly lower in Postn−/− mice than wt only in the DMM model (1.88 ±
1.01 vs. 3.17 ± 0.63; P = 0.039). Postn−/− mice also showed lower trabecular bone parameters such as BV/TV, vBMD,
Tb.Th, and Tb.N and high Tb. Sp in both models. Postn−/− mice had negligible levels of serum Postn compared with
wt. Immunofluorescent studies of cartilage indicated that Postn−/− mice expressed lower MMP-13 levels than wt
mice. RNA-seq revealed that cell-cell-adhesion and cell-differentiation processes were enriched in Postn−/− mice,
while those related to cell-cycle and DNA-repair were enriched in wt mice.
(Continued on next page)
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Conclusions: Postn deficiency protects against DMM-induced post-traumatic and age-related spontaneous OA.
RNA-seq findings warrant further investigations to better understand the mechanistic role of Postn and its potential
as a therapeutic target in OA.
Keywords: Periostin, Knee osteoarthritis, Trauma, Aging, MMP-13, RNA-seq

Introduction
Osteoarthritis (OA) is a clinical syndrome that affects
more than 50 million people in the USA, with $185 billion in annual socioeconomic costs [1, 2]. Currently,
there are no proven treatments to delay, let alone prevent, the progression of OA. Thus, a treatment that
slows or halts disease progression before end-stage joint
failure and arthroplasty is sorely needed. OA is recognized as a whole joint disease that affects all tissues
(bone, cartilage, synovium, meniscus, and ligaments) [3,
4], although cartilage degeneration is considered the
hallmark of end-stage disease [5]. Despite advances in
preclinical studies, the pathways controlling early cartilage degeneration and new bone formation in OA remain
unknown. Therefore, a critical issue in OA treatment is
discovering early OA mediators, particularly elucidating
the underlying intracellular signal transduction pathways, which affects multiple tissues in the joints.
Emerging evidence indicates periostin (Postn) is upregulated in patients with OA [6–9] and has been identified as a gene of interest in articular cartilage [10–12].
Postn is a vitamin K-dependent and glutamatecontaining matricellular protein [13]. Postn, a member
of the fasciclin family of proteins, was originally called
osteoblast-specific factor 2 [14]. First identified in murine osteoblasts, it is also found in the periosteum [15].
Postn plays key roles in health and disease across various
disciplines such as osteology and oncology [16–20]. It
also plays a role in the repair mechanism of many connective tissues and organs such as the periodontal tissue,
heart, and lungs [15, 16, 20–23]. Postn is considered important for its role in maintaining tissue integrity. In the
bone, Postn is predominantly expressed in the periosteum and considered a key extracellular matrix (ECM)
protein needed in health and healing. For instance, loss
of Postn influences the propensity to fatigue fractures in
mice [24], and Postn-deficient periosteum cannot reconstitute stem cells after injury [25]. Despite this evidence
for the importance of Postn, it also has an adverse role
in various inflammatory settings [26–28].
We have shown that expression of Postn is induced
following joint trauma such as destabilization of the
medial meniscus (DMM) or anterior cruciate ligament
transection/partial medial meniscectomy and leads to
development and progression of OA [12, 22]. Recently,
our data confirmed that the Postn expression increases

significantly in mouse and human cartilage and osteophytes during OA progression. Immune-localization
studies further revealed that Postn was present in the
cartilage ECM [10, 12, 22]. Emerging evidence supports
the involvement of Postn in Wnt signaling activation
and MMP-13 expression. Postn-induced MMP-13 expression was also inhibited by CCT031374 hydrobromide, an inhibitor of the canonical Wnt/β-catenin
signaling pathway [12]. These findings suggest a catabolic role for Postn in promoting cartilage degeneration
in OA by upregulating MMP-13 in response to injury.
In the present study, we hypothesize that genetic Postn
loss-of-function in mice would protect against cartilage
degeneration, synovitis, and bone changes secondary to
aging and knee injury. To test this hypothesis, we
assessed cartilage degeneration, synovial pathology, and
bone morphometric parameters in two animal models.
One consisting of 24-month-old mice with spontaneous
OA and one with surgically induced OA model in 10week-old mice. Postn knockout mice were compared to
wild-type (wt) in both cohorts. We also performed
RNA-seq on chondrocytes isolated from both Postn−/−
and wt mice in a pursuit to identify genes and pathways
altered following Postn knockout.

Methods
Animals

In this study, we used homozygous mutant Postntm1Jmol/J
(Postn−/−; Stock No. 009067) mice on a B6129SF2/J (wt;
Stock No. 101045) background. Postn−/− and wt mice
were obtained from The Jackson Laboratories (Bar Harbor, ME). Post-traumatic OA studies were performed at
Washington University (St. Louis, MO), and aging studies were conducted at New York University Grossman
School of Medicine (New York, NY). Postn−/− mice were
obtained by crossing heterozygous mice, and littermate
mice from the same breeding were used for all experiments. All mice were kept and bred at the study institutions and genotyped by polymerase chain reaction (PCR)
using tail deoxyribonucleic acid separated on 1.5% agarose gel using standard methods. Mice were housed in individually ventilated cages, with each cage having no
more than five mice at a time in a hygienic barrier facility operating at 21–22 °C. Food and water were available
ad libitum, and animals were maintained in a 12-h light,
12-h dark cycle. We used only male mice given sex
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differences in the DMM model [29]. The number of
mice in each experimental group and each genotype are
indicated in figure legends and summarized in Table 1.
Detection of Postn protein in the murine serum

Postn deficiency in Postn−/− mice was detected by solidphase enzyme-linked immunosorbent assay (ELISA).
Briefly, mice euthanized by carbon dioxide asphyxiation
were exsanguinated by cardiac puncture using minicollect serum separator tubes (Greiner Bio-One, Monroe, NC). The blood was allowed to clot at room
temperature for 30 min and retract at 4 °C for 4 h. The
clotted blood was centrifuged at 2500 rpm at 4 °C for 10
min. The serum was collected, centrifuged, and stored at
− 20 °C until used. Postn concentration in serum was
measured using a mouse periostin/OSF-2 Quantikine
ELISA kit according to the manufacturer’s instructions
(MOSF20, R&D Systems Inc., Minneapolis, MN). In
brief, 50 μl assay diluent was added to each well of a 96well strip plate followed by an equal volume of standard,
control, and sample in individual wells. The plate was
incubated at room temperature on a horizontal orbital
microplate shaker. After 2 h of incubation, the contents
were removed, and each well was washed five times with
the supplied wash buffer. Subsequently, 100 μl conjugate
was added to each well followed by 2-h incubation at
room temperature with constant shaking. Then, following washing as above, the plate was incubated with
100 μl substrate solution in each well for 30 min. Finally,
the reaction was terminated with the addition of 100 μl
of stop solution and the plate was read at 450 nm within
30 min.
Induction of post-traumatic OA

To determine the role of Postn loss-of-function in posttraumatic OA, we performed the DMM surgery on 10week-old male Postn−/− or wt mice as described [30].
In short, mice were anesthetized with 2.5% isoflurane in
4 L/min oxygen. After aseptic preparation of the right
Table 1 Distribution of mice for each experiment
Genotype
−/−

Postn

wt

Age

Experiment

n

10 weeks

DMM

10

24 months

Aging

7

24 months

Serum

6

21 days

RNA-seq

3

21 days

Real-time PCR

6

10 weeks

DMM

10

24 months

Aging

6

24 months

Serum

11

21 days

RNA-seq

3

21 days

Real-time PCR

6

hind limb, the joint capsule immediately medial to the
patellar tendon was cut open, and the anterior attachment of the medial meniscotibial ligament was severed
with sterilized microsurgical tools. This step resulted in
the destabilization of the medial meniscus. Afterward,
the joint capsule was closed with 6–0 absorbable polypropylene sutures (Ethicon, Blue Ash, OH), and the skin
was closed by Vetclose skin glue (Henry Schein, Melville,
NY). However, we used the contralateral left hind limb as
non-operated control to avoid the effect of surgery. In
compliance with guidelines, sustained-release buprenorphine (1.0 mg/kg) was administered once as an analgesic
before surgery. No other pain-relieving medication was
given to the mice. All mice were weight-bearing following
recovery from the general anesthesia and resumed previous cage activity, water consumption, and food intake.
Mice were euthanized 8 weeks after surgery by carbon
dioxide inhalation. Hind limbs were separated, skinned,
and subjected to histological and micro-computed tomography (μCT) analyses.
Age associated spontaneous OA

For aging studies, 24-month-old wt and Postn−/− mice
were sacrificed using carbon dioxide asphyxiation; the
hind limbs were separated, skinned, and prepared for
histological and μCT analyses.
Histological assessment of cartilage degeneration and OA

The knee joints were fixed in 10% neutral-buffered formalin for 48 h and decalcified using 12% formic acid,
then embedded in paraffin using standard methods.
Twelve coronal sections, each with 5 μm thickness, were
taken from each joint at eight levels separated by 80 μm
intervals. From each level, three sections were stained
with Safranin O [31]. In each genotype, the same number and depth of sections were evaluated. The semiquantitative Osteoarthritis Research Society International (OARSI) scoring system (scale: 0–6) was used
to assess cartilage damage [32]. Cartilage damage was
measured and scored in all four tibiofemoral compartments of the knee (lateral and medial femoral condyles
and lateral and medial tibial plateaus) at all sectioned
levels. The maximum OARSI score representing the
highest score within all sectioned levels of the knee was
recorded. Summed OARSI score was calculated by adding the total scores of four consecutive levels of each
knee. Two independent scorers blinded to genotype and
procedure scored the sections with a high inter-rater
reliability.
Histological assessment of synovitis

Safranin O-stained sections were graded for synovitis in
the medial compartment for two parameters using a
method developed by Lewis and colleagues [33].

Attur et al. Arthritis Research & Therapy

(2021) 23:104

Enlargement of the synovial lining cell layer is measured
on a scale of 0–3, separately from the cells’ density in
the synovial stroma on a scale of 0–3. Synovitis scores
obtained for both of these parameters were averaged
separately, and the sum of averages from both parameters used for analysis on a scale of 0–6.
Immunostaining for Postn and MMP-13

Histological sections were deparaffinized using xylene and
then rehydrated in a graded series of ethyl alcohol. Endogenous peroxidase activity quenched by incubating slides
with 3% (v/v) hydrogen peroxide in phosphate-buffered saline (PBS). After 15 min of incubation, proteinase K (10 μg/
mL, Abcam, Cambridge, MA) was added to the sections for
20 min at 37 °C to retrieve the antigen. Following washing
with PBS and blocking with 10% normal goat serum
(NGS), slides were allowed to react overnight at 4 °C with
the following primary antibodies diluted in 2% NGS: antiperiostin (1:100, Sigma-Aldrich, St. Louis, MO), MMP-13
(1:200, Abcam), and in-house collagen type II (Col 2, 1:
200). The next day, following the washing step, slides were
incubated with the corresponding HRP- (for Postn), Alexa
488-(MMP-13), or Alexa 594-(for Col 2) conjugated secondary antibody in 2% NGS for one-hour room
temperature. Then, slides (MMP-13 and Col 2) underwent
counterstaining with Fluoro-Gel II with 4′,6-diamidino-2phenylindole (DAPI, Electron Microscopy Sciences, Hatfield, PA) for MMP-13 and Col 2. For immunohistochemical staining of Postn, HRP stained slides were developed
with 3,3’-Diaminobenzidine (DAB Chromogen Kit; Vector
Laboratories Inc., Burlingame, CA) for 10 min at room
temperature. All images were visualized using a NanoZoomer (Hamamatsu Corp., Bridgewater, NJ) or Confocal
Laser Scanning Microscope (Leica, Biosystems, Buffalo
Grove, IL). MMP-13 expression levels were quantified by
measuring the staining intensity of 20–40 cells in each
stained section using LAS X software (Leica Biosystems).
μCT analysis of the trabecular bone

After fixation but before decalcification, the knees undergoing DMM were scanned using a vivaCT 40 in vivo μCT
scanner (Scanco Medical Inc., Southeastern, PA) with the
following setting: voxel size = 21 μm, energy = 45 kV, intensity = 177 μA, and integration time = 300 ms [34]. To
analyze bone changes, the femoral epiphysis was chosen as
the region of interest. The region of interest was identified
between the cartilage and the growth plate. The outline of
the epiphysis was carefully selected without the inclusion of
outgrowing osteophyte(s). Knees from 24-month-old mice
were scanned using a 10 MP digital detector using the following parameters: 10 W of energy (50 kV and 200 mA),
pixel size = 9.7 μm, exposure = 1025 ms/frame, rotation step
0.3 degrees with × 10 frames averaging, 0.5 mm Aluminum
filter, and scan rotation = 180o. After scanning, the
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radiographs were reconstructed using NRecon software ver.
1.7.3.0 (Bruker μCT, Kontich, Belgium). Reconstruction
was done with NRecon using GPU acceleration. Gaussian
smoothing was applied with a 2-voxel radius, ring artifact,
and beam hardening corrections were applied in reconstruction. Ring artifact reduction set to 7 pixels. Beam hardening correction was set to 40%. Following trabecular bone
morphometric parameters defined by the American Society
for Bone and Mineral Research were analyzed [35]: bone
volume fraction (BV/TV), volumetric bone mineral density
(vBMD), trabecular thickness (Tb.Th), trabecular number
(Tb.N), and trabecular spacing (Tb.Sp).
RNA-Seq analysis, gene ontology annotation, and
transcript expression validation

We performed bulk RNA-seq on articular chondrocytes
isolated from Postn−/− and wt mice to determine the baseline transcript-level differences between the two genotypes.
Chondrocyte isolation and culture

Primary chondrocytes were isolated from femoral head cartilage of 21-day-old Postn−/− (n = 3) and wt (n = 3) mice as
described previously [36]. The cells were seeded in 24-well
plates, supplied with 10% fetal bovine serum (FBS; Thermo
Fisher Scientific, Waltham, MA) in high glucose Dulbecco’s
modified Eagle’s medium (DMEM; Thermo Fisher Scientific) supplemented with 1% penicillin and streptomycin
(10,000 U/mL and 10,000 ug/mL respectively;, Thermo
Fisher Scientific) and incubated at 37 °C in a humidified incubator with 5% CO2. After 2 days of culture, cells were
washed 3× with PBS before RNA extraction.
RNA extraction

Total RNA was extracted from 1.0 × 105 cells using a
column-based RNeasy Mini kit (Qiagen, Valencia, CA). Total
RNA quality and concentrations were measured using Agilent Bioanalyzer (Agilent Technologies Inc., Santa Clara, CA).
RNA samples with a RIN (RNA integrity number) score > 9.0
were used for RNA-seq analysis and real-time PCR.
Library preparation, sequencing, and gene ontology
analysis

Library preparation was performed with 10 ng of total
RNA. Double-stranded cDNA was prepared using Clontech SMARTer Ultra Low RNA kit (Takara Bio Inc.,
Mountain View, CA). cDNA was fragmented with an
E220 sonicator (Covaris Inc., Woburn, MA) using these
settings: peak incident power = 18, duty factor = 20%,
and cycles per burst = 50 for 120 s. cDNA was bluntended, had an A base added to the 3′ ends, and had Illumina sequencing adapters ligated to the ends. Ligated
fragments were amplified for 12–15 cycles using primers
incorporating unique dual index tags. Fragments were
sequenced on an Illumina HiSeq 3000 (Illumina, San
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Diego, CA) using single-end reads extending 50 bases.
Base calls and demultiplexing performed with Illumina’s
bcl2fastq software, and a custom python demultiplexing
program with a maximum of one mismatch in the
indexing read. RNA-seq reads were aligned to the
Ensembl release 76 top-level assemblies with STAR version 2.0.4b [37]. Gene counts were derived from the
number of uniquely aligned unambiguous reads by Subread:featureCount version 1.4.5 [38]. Sequencing performance was assessed for the total number of aligned
reads, the total number of uniquely aligned reads, and
features detected. The ribosomal fraction, known junction saturation, and read distribution over known gene
models were quantified with RSeQC version 2.3 [39].
All gene counts imported into the R/Bioconductor
package EdgeR [40], and TMM normalization size factors were calculated to adjust for samples for differences
in library size. Ribosomal genes and genes not expressed
in the smallest group size minus one sample greater than
one count-per-million excluded from further analysis.
The TMM size factors and the matrix of counts were
then imported into the R/Bioconductor package Limma
[41]. Weighted likelihoods based on the observed meanvariance relationship of every gene and sample were
then calculated for all samples with the voomWithQualityWeights [42] function with additional unknown latent
effects as determined by surrogate variable analysis [43].
All genes performance assessed with plots of the residual
standard deviation of every gene to their average logcount with a robustly fitted trend line of the residuals.
Differential expression analysis was performed to analyze
for differences between conditions, and the results were
filtered for only those genes with Benjamini-Hochberg
false-discovery rate (FDR) adjusted P ≤ 0.05.
For each contrast extracted with Limma, global perturbations in known Gene Ontology (GO) terms detected
using the R/Bioconductor package “Generally Applicable
Gene set Enrichment” [44] to test for changes in expression of the reported log2-fold changes reported by
Limma in each term versus the background log2-fold of
all genes found outside the respective term. The R/Bioconductor package heatmap3 [45] used to display heatmaps across groups of samples for each GO term with a
Benjamini-Hochberg FDR-adjusted P ≤ 0.05.
Validation of RNA-seq data by quantitative real-time PCR

We validated RNA-seq data by quantitative real-time
PCR. We selected representative genes for each pattern
of expression. Expression of Dscaml1 and Tm4sf1 was
higher in Postn−/− and wt mice respectively, expression
of Ndufs5 and Srsf10 was similar in both groups. Total
RNA was prepared from chondrocytes isolated from
Postn−/− mice (n = 6) and wt mice (n = 6) mice. A total of
250 ng of total RNA was subjected to Amplification Grade
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DNase I treatment (1 U/μL, Thermo Fisher Scientific), to
eliminate traces of genomic DNA and then reverse transcribed to synthesize the first strand of cDNA (High-Capacity Reverse Transcription Kit, Thermo Fisher Scientific).
Briefly, 2 μL cDNA was added to the reaction mixture
comprising of 2× SYBR Green Master Mix (Thermo
Fisher Scientific), gene-specific forward and reverse
primers (primer sequences are depicted in Table 2), and
RNase-free water to reach a total volume of 20 μL. Subsequently, real-time PCR was performed under the following
settings: 94 °C for 3 min, followed by 40 cycles at 94 °C for
30 s, 60 °C for 30 s, and 72 °C for 30 s. The target gene expression was normalized to the housekeeping gene,
Gapdh. Each analysis was performed in triplicate. The
relative expression values were computed using 2−ΔΔCt
method.
Statistical analysis

The non-parametric Mann-Whitney test used to compare the data from two genotypes (wt and Postn−/−) unless indicated otherwise. Results were considered
statistically significant at P < 0.05. Data are presented as
mean ± standard deviation with 95% confidence interval
(CI) where indicated. All statistical analyses were performed using GraphPad PRISM version 7.03 (GraphPad
Software Inc., San Diego, CA).

Results

Postn−/− mice exhibit no Postn in the joint and in the
serum

The genotype of each mouse was confirmed by PCR
(Fig. 1a–c). We demonstrated a complete loss of Postn
protein in Postn−/− mice by immunostaining of the joint
section (Fig. 1d) and ELISA in serum. ELISA results revealed significantly low levels of Postn protein in the
serum of Postn−/− mice compared with the wt mice
(28.33 ± 21.65 [95% CI = − 4.88–61.55] vs. 3827.00 ±
2504.00 [95% CI = 2144.00–5509.00], P = 0.0002) (Fig. 1e).
Postn−/− mice develop less severe OA after DMM
Cartilage degeneration

The analysis of histological sections of DMM-operated or
non-operated knees from Postn−/− and wt mice at 8-weeks
after DMM surgery (Fig. 2a) showed that non-operated
control mice retained relatively normal cartilage with maximum OARSI score ≤ 1.00. Conversely, many histological
features representative of OA were apparent 8 weeks after
surgery in wt mice: reduced Safranin O staining depicting
proteoglycan loss in the ECM, fibrillation, and delamination
of superficial zone cartilage, and in severe cases, an extension of the cleft lesions into the middle zone. These features
illustrate that DMM surgery-induced degeneration of the
cartilage resembles human OA pathology. The mean maximum OARSI score for wt mice in DMM-operated knees

Attur et al. Arthritis Research & Therapy

(2021) 23:104

Page 6 of 14

Table 2 Sequence and characteristics of primers used for real-time PCR
Gene symbol

Forward primer (5′ → 3′)

Location

Reverse primer (5′ → 3′)

Location

Amplicon size

Accession no.

Dscaml1

aggctgaagaggctacgaga

4972–4991

gaggtcctttcacaggggtg

5062–5043

91 bp

NM_001081270.2

Tm4sf1

actgggtttggcagaaggac

1006–1025

tgggctcatagcacttggac

1127–1108

122 bp

NM_008536.4

Ndufs5

acagccctataagaacgccg

148–167

tgtaccgaagcaagcactct

287–268

140 bp

NM_001030274.1

Srsf10

acgtcgggaatttggtcgtt

234–253

agcgtcttcagcatcacgaa

357–338

124 bp

NM_010178.3

Gapdh

aggtcggtgtgaacggatttg

100–120

tgtagaccatgtagttgaggtca

222–200

123 bp

NM_001289726.1

bp = base pair

(4.00 ± 1.20; 95% CI = 3.00–5.00) was significantly (P <
0.001) higher than that of non-operated control knees
(0.75 ± 0.46; 95% CI = 0.36–1.14). Postn−/− mice that
underwent DMM showed significantly less cartilage damage with the mean maximum OARSI score of 2.37 ± 0.74
(95% CI = 1.75–3.00), significantly (P = 0.011) lower than
for their littermate wt mice (4.00 ± 1.20; 95% CI = 3.00–
5.00) (Fig. 2b). Likewise, DMM-operated Postn−/− mice
(9.31 ± 2.52, 95% CI = 7.21–11.42) had significantly (P =
0.0002) lower mean summed OARSI score than wt mice
(21.44 ± 6.01, 95% CI = 16.41–26.46) (Fig. 2c).
Synovitis

We noted a thinner synovial lining cell layer and a low
density of cells in the synovial stroma in Postn−/− mice
than wt mice (Fig. 2d). Quantification of synovitis score
was significantly (P = 0.039) lower in Postn−/− mice

(1.88 ± 1.01; 95% CI = 0.82–2.93) than wt mice (3.17 ±
0.63; 95% CI = 2.51–3.82) (Fig. 2e).

Trabecular bone changes

Interestingly, there were no differences in the bone parameters measured in the control/contralateral limbs between the genotypes (Table 3). The differences in the
various parameters of trabecular bone between wt and
Postn−/− are shown in Fig. 2f. We noted that the following bone parameters were significantly lower in Postn−/−
mice compared with wt mice: trabecular BV/TV (9.8%,
P = 0.009), vBMD (11.3%, P = 0.029), Tb.Th (25.6%, P =
0.043), and Tb.N (14.6%, P = 0.012). In contrast, Tb. Sp
was significantly higher in Postn−/− mice than wt mice
(17.2%, P = 0.023).

Fig. 1 Postn−/− mice lack Postn protein. a Primers used for mouse genotyping. b Diagram of targetting vector for genertaion of Postn−/− mice. c
Genotyping analysis of wt, Postn−/− and Postn+/− mice. d Immunostaining of Postn in the knee joint revealed that wt (n = 3) mice expressed
periostin (red arrows) whereas Postn−/− (n = 3) mice showed no staining for Postn (left panel: 10x, right panel 20x). Scale bar = 100 μm. e Serum
Postn levels were negligible and significantly low in Postn−/− (n = 6) than wt mice (n = 11) (Mann-Whitney test)
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Fig. 2 Postn−/− mice are protected from post-traumatic OA. a Histological analysis of the cartilage showed that DMM-operated limbs exhibited
increased cartilage degeneration than non-operated control limbs. Cartilage degeneration in wt mice was markedly higher (dotted boxes) than
Postn−/− mice (arrows). b Semi-quantitative analysis of cartilage degeneration by maximum OARSI score showed that Postn−/− mice (n = 8) had
significantly less maximum OARSI score than wt mice (n = 8). (Mann-Whitney test). c Semi-quantitative analysis of cartilage degeneration by summed
OARSI score showed that Postn−/− mice (n = 8) had significantly less summed OARSI score than wt mice (n = 8). (Mann-Whitney test). d Synovitis was
evaluated by measuring synovial lining cell layer and density of cells in the synovial stroma. e Semi-quantification of synovitis score was significantly
lower in Postn−/− mice (n = 6) than wt mice (n = 6). (Mann-Whitney test). f μCT analysis showed that Postn−/− mice (n = 10) had significantly lower BV/
TV. vBMD, Tb.Th and Tb.N and significantly higher Tb. Sp than wt mice (n = 10) in the DMM-operated limb (Mann-Whitney test)

24-month-old Postn−/− mice demonstrated protection
from spontaneous OA
Cartilage degeneration

Representative histological sections from 24-month-old
Postn−/− and wt mice are shown in Fig. 3a. Histological
analysis of the knee joints of 24-month-old Postn−/− and
wt mice showed that Postn−/− mice had less cartilage degeneration (only focal loss of proteoglycans without

cartilage loss) than wt mice, which exhibited increased
loss of cartilage proteoglycan and delamination of both
superficial and middle zones. These observations confirmed that in mice, aging induces spontaneous cartilage
degeneration that resembles OA pathology in humans.
The mean maximum OARSI score in Postn−/− mice was
significantly lower than in wt mice (1.93 ± 0.45 [95% CI =
1.51–2.35] vs. 3.58 ± 1.16, [95% CI = 2.37–4.80], P =

Table 3 Bone epiphysial parameters in control limbs of wt and Postn−/−mice
Postn−/−

Parameter

wt
Mean ± SD

95% CI

Mean ± SD

95% CI

BV/TV (mm3/mm3)

0.79 ± 0.04

0.76–0.82

0.73 ± 0.09

0.66–0.79

0.143

vBMD (mg HA/cm )

650.70 ± 57.35

609.70–691.70

608.90 ± 103.60

534.70–682.90

0.436

Tb.Th (mm)

0.20 ± 0.11

0.13–0.28

0.15 ± 0.03

0.13–0.17

0.248

Tb.N (1/mm)

14.46 ± 2.54

12.64–16.28

15.33 ± 2.87

13.28–17.39

0.631

Tb.Sp (mm)

0.07 ± 0.02

0.06–0.08

0.06 ± 0.01

0.05–0.07

0.353

3

SD standard deviation, CI confidence interval

P
value
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Fig. 3 Postn−/− mice are protected from age-related spontaneous OA. a Histological analysis of cartilage showed that wt mice developed
significant cartilage degeneration at 24-month of age whereas age-matched Postn−/− mice did not develop any degeneration in the articular
cartilage. b Semi-quantitative analysis of cartilage degeneration using maximum OARSI score displayed that Postn−/− mice (n = 7) had significantly
less maximum OARSI score than wt mice (n = 6) (Mann-Whitney test). c Semi-quantitative analysis of cartilage degeneration using summed OARSI
score displayed that Postn−/− mice (n = 7) had significantly less summed OARSI score than wt mice (n = 6) (Mann-Whitney test). d Synovitis was
assessed by semi-quantiative analysis of synovial lining cell layer and density of cells in the synovial stroma. e Semi-quantification of synovitis
score was not significantly different between the genotypes (n = 6 each). (Mann-Whitney test). f μCT analysis showed that Postn−/− mice (n = 5–
7) had significantly lower BV/TV, vBMD, Tb.Th, and Tb.N and higher Tb. Sp than wt mice (n = 5–6) in the DMM-operated limbs
(Mann-Whitney test)

0.014) (Fig. 3b). Similarly, the mean summed OARSI
score was significant (P = 0.003) lower in Postn−/− mice
(6.14 ± 1.57, 95% CI = 4.69–7.60) than wt mice (11.50 ±
3.02, 95% CI = 8.33–14.67) (Fig. 3c).
Synovitis

The synovial lining cell layer and cell density in the synovial stroma appeared similar in both genotypes (Fig.
3d). We did not find any significant (P > 0.999) difference in synovitis score between Postn−/− mice (3.33 ±
1.63; 95% CI = 1.62–5.05) and wt mice (3.33 ± 1.63; 95%
CI = 1.62–5.05) (Fig. 3e).

mice. Also, Tb. Sp was 24.0% higher in Postn−/− than wt
mice but did not reach significance (P = 0.138).
MMP-13 expression decreased in Postn−/− mice

Immuno-fluorescence analysis of MMP-13 revealed that
its expression was increased in wt mice following DMM
compared with the control knees. In contrast, no MMP13 was detected in DMM-operated knees of Postn−/−
mice (Fig. 4a). Semi-quantitative assessment of immunofluorescence imaging further showed that intensity of
MMP-13 staining was significantly (P = 0.029) lower in
Postn−/− (6.73 ± 5.23, 95% CI = -1.60–15.06) than wt
mice (28.18 ± 14.94, 95% CI = 4.42–51.95) (Fig. 4b).

Trabecular bone changes

RNA-seq and gene ontology analyses

The changes in different trabecular bone parameters are
depicted in Fig. 3f. We observed that Postn−/− mice exhibited significantly lower trabecular BV/TV (54.7%, P =
0.009), vBMD (20.9%, P = 0.016), Tb.Th (12.2%, P =
0.044) and Tb.N (49.7%, P = 0.005) in contrast to wt

Qualitative gene expression analysis revealed that samples were clustered into two distinct clusters of Postn−/−
and wt chondrocytes based on principal component analysis indicating a specific expression profile (Fig. 5a)
though there was higher variation among samples from
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Fig. 4 Postn−/− mice expressed less MMP-13 than wt mice after DMM. a Immunofluorescent analysis showed that MMP-13 staining (green) was
higher in cartilage of DMM-operated limbs than in the non-operated control limb. Postn−/− mice (n = 4) showed less staining of MMP-13 than wt
mice (n = 4). Type II collagen (Col 2) (red) staining was used for location of cartilage. The dotted lines on lower panels indicate the Col 2-positive
cartilage area based on the results in the upper panels. DAPI (blue) was used as a counterstain. Scale bars = 100 μm. b Quantification of
immunostaining intensity of MMP-13 showed that MMP-13 intensity was significantly lower in Postn−/− mice (n = 4) than wt mice (n = 4).
(Mann-Whitney test)

Fig. 5 Descriptive RNA-seq data and real-time PCR. a Principal component analysis of chondrocytes samples from wt (n = 3) and Postn−/− (n = 3)
mice showed distinct grouping based on gene expression differences. b MA (log2 ratio to mean expression) plot depicts expression fold change
and averaged expression level of differentially expressed transcripts. c Volcano plot of all genes expressed greater than 1 count-per-million in all 6
samples where the observed log2 fold change is on the x-axis and the unadjusted P value converted to the −log10 scale is on the y-axis. Twelve
genes with unadjusted P ≤ 0.05 are highlighted in red when log2 fold changes > + 2 and blue when < – 2. d Real-time PCR performed on
chondrocytes isolated from an independent cohort of wt (n = 6) and Postn−/− (n = 6) mice revealed an agreement with the RNA-seq data. (Mann
Whitney test)

Attur et al. Arthritis Research & Therapy

(2021) 23:104

Page 10 of 14

wt mice than Postn−/− mice. Moreover, we show that expression fold change and average expression levels vary
subtly in a mean average (log2 ratio to mean expression
plot) (Fig. 5b).
Detection of differentially expressed gene transcripts

Gene transcripts (Supplemental Table 1) were significantly differentially expressed (n = 1247) between
Postn−/− and wt chondrocytes at an unadjusted P ≤ 0.05
with 727 being upregulated in Postn−/− while 520 were
upregulated in wt chondrocytes. Out of 1247, only 48
transcripts had log2 fold-change ≥2. After, FDR ≤ 0.05
correction, only four transcripts (Table 4) were found to
be differentially expressed (3 upregulated and 1 downregulated) between Postn−/− compared with wt. Volcano
plot of genes expressed greater than 1 count-per-million
in all six samples is shown (Fig. 5c).
Gene ontology annotation

Gene ontology analysis revealed that a number of distinct biological processes were significantly enriched for
each genotype (Table 5). While the biological processes
related to cell-cell adhesion, cell signaling, cell differentiation, focal adhesion, and angiogenesis were elevated in
Postn−/− mice, biological processes such as cell cycle, cell
division, and DNA repair repressed in Postn−/− mice.
Validation by real-time PCR

We further confirmed the differentially expressed genes
by quantitative real-time PCR in agreement with the
RNA-seq data (Fig. 5d).

Discussion
Our study illustrates that Postn deficiency exerts a protective effect against OA in mice. Specifically, mice lacking the Postn gene displayed significantly less cartilage
degeneration than wt control mice in post-traumatic OA
as well as age-related primary OA. Postn deficiency also
appears to wield protective effects by modulating
changes in the synovium and bone. Thus, our findings
highlight that Postn loss-of-function protects against incidence and progression of OA independent of the
cause, i.e., primary age-related spontaneous OA as well
as injury-induced post-traumatic OA.
In both mouse models of OA, Postn−/− mice retained
superior cartilage and exhibited less degenerative

changes as measured by OARSI scores. These findings
are consistent with the notion that protection from cartilage degeneration parallels protection from OA since
cartilage degeneration is considered OA’s hallmark [4].
Besides, we also showed that Postn−/− mice developed
significantly less synovitis than wt mice after DMM.
Tajia et al. have also shown increased expression of
Postn in human OA synovium [46]. These protective effects of Postn loss-of-function on the cartilage and synovium indicate decreased catabolic activity in the joint.
Our observation aligns with our previous in vitro work
showing that siRNA-mediated knockdown of Postn in
chondrocytes results in reduced expression of inflammatory and catabolic markers such as IL-1β, ADAMTS-4/5,
and MMP-13 [12, 22].
We also found differences in trabecular bone parameters between the genotypes (Postn−/− and wt) for both
OA models. BV/TV, vBMD, Tb.Th, and Tb.N was low
and Tb. Sp was high in Postn−/− mice. These parameters
are not only standard osteoporosis measurements but
have also been used as markers for OA [47–49]. The
pattern of these bony changes in Postn−/− mice mirrors
OA protection as has been noted in rodent and human
studies of OA [31, 47–52]. These findings suggest that
Postn plays a role in modulating changes in cartilage as
well as in the bone. However, it is not possible to conclude that the bone is driving the cartilage phenotype
from this investigation.
In the present study, we did not examine how the genetic deficiency of Postn protects mice from developing
OA. However, several studies suggest a possible link
connecting the mechanisms of Postn-mediated cartilage
degeneration with NF-κB and Wnt signaling [7, 12, 22,
53]. We have previously shown that Postn expression is
increased following injury [12]. Postn is upregulated in
human OA cartilage and cartilage from mice undergoing
DMM and is correlated with increased MMP-13 expression in OA cartilage [12, 22]. Increased expression of
Postn leads to overexpression of cartilage ECM degrading enzymes such as MMP-13 and ADAMTS-5. Postn
also promotes condylar resorption via the NF-κBADAMTS-5 axis in temporomandibular joint OA [54].
Overexpression of Postn by the administration of recombinant proteins or through lentivirus transduction leads
to increased expression of MMP-13 in human and murine chondrocytes. Likewise, Postn inhibition or

Table 4 Gene transcripts differentially expressed in chondrocytes between Postn−/− and wt mice
Gene symbol
Evx2

Gene name
Even skipped homeobox 2

Log2 fold change
3.14

Description

P
−6

Up-regulated in Postn−/− mice

−5

5.30 × 10

Dscaml1

DS cell adhesion molecule like 1

2.62

1.22 × 10

Up-regulated in Postn−/− mice

Gdf10

Growth differentiation factor 10

1.05

7.85 × 10−6

Up-regulated in Postn−/− mice

Tm4sf1

Transmembrane 4 superfamily member 1

−6.59

−7

1.27 × 10

Down-regulated in Postn−/− mice
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Table 5 Biological processes (gene ontologies) altered in chondrocytes between Postn−/− and wt mice

deficiency results in decreased expression of catabolic
enzymes. Therefore, we surmise that loss of Postn protects against cartilage degeneration by decreasing ECM
degrading enzymes such as MMP-13 and ADAMTS-5.
A recent study identified DDR-1 as a potential receptor
for Postn-mediated signaling in chondrocytes. It showed
that blocking DDR-1 with small chemical inhibitors reduced MMP-13 expression and cartilage degradation
in vitro and in vivo [53].
Baseline transcriptomic differences between Postn−/−
and wt mice revealed interesting findings. The expression of Evx2, Dscaml1, and Gdf10 increased in Postn−/−
compared with wt mice. Evx2 is predominantly
expressed in the limbs and is involved in vertebrate
limbs’ morphogenesis, where it interacts with Hox genes
[55]. Dscaml1 is a member of the immunoglobulin
superfamily of cell adhesion molecules, which participates in neuronal differentiation [56]. Tuure et al. reported that the expression of Dscaml1 is low in human
OA chondrocytes treated with IL-1β and is increased
following treatment with a selective inhibitor of microsomal prostaglandin E synthase 1 [57]. Gdf10 gene encodes a secreted ligand of transforming growth factorbeta superfamily of proteins, which plays essential functions in chondrocyte differentiation and bone formation
[58]. In particular, it was found that the expression of
Gdf10 was increased in chondrocytes under hypoxia,
where Gdf10 was regulated by Sox-9, suggesting its protective role in chondrocytes [59]. The expression of
Tm4sf1 was decreased in Postn−/− mice. Tm4sf1 is a surface marker, known to inhibit apoptosis and promote
cell proliferation and migration [60]. This transcriptomic
profile paralleled with gene ontology annotations. For instance, the biological processes related to cell-cell adhesion, cell signaling, cell differentiation, and focal
adhesion were elevated in Postn−/− mice, while biological

processes such as cell cycle, cell division, and proliferation were repressed in Postn−/− mice. Together, these
findings provide novel insights into the role of Postn in
chondrocytes, specifically highlighting that increased expression of Dscaml1 and Gdf10 (and related biological
processes) offers protection from OA, while the expression of Tm4sf1 (and related biological processes) related
to cellular phenotypes that are altered with Postn knockout. While the role of Postn in OA has been discussed
in the previous paragraph, here, we highlight its role in
cell functions. Chinzei et al. showed that exogenous
overexpression of Postn increases chondrocyte migration
which is impeded by its knockdown [22]. Likewise,
Padial-Molina et al. reported an increase in proliferation
and migration of periodontal ligament fibroblasts with
Postn treatment [61]. Finally, Cai and colleagues showed
that Postn knockdown decreases cell matrix [23]; however, no data are yet available for cell-cell-adhesion in
the context of Postn knockdown or overexpression in
chondrocytes.
Our finding that Postn deficiency reduces both agerelated spontaneous OA and post-traumatic OA is important. While aging and obesity are associated with primary idiopathic OA [62–65], joint injuries cause posttraumatic OA cases [66, 67] and constitute at least 12%
of OA [68]. While both OA forms are qualitatively similar in that both share standard features such as cartilage
degeneration and bone sclerosis [69], the underlying disease mechanisms are dissimilar in many ways [10]. However, their degree of overlap is unclear, particularly at
the mechanistic level. Our finding that Postn deficiency
protected the joint from cartilage degeneration and bone
alterations in both types of OA suggests that Postn ablation may have widely applicable therapeutic efficacy.
Specifically, anti-Postn therapy may have utility for primary idiopathic OA as well as for post-traumatic OA.
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In this study, we have shown that global deletion of Postn
is protective against OA. Postn knockout is embryonically
non-lethal, yet some Postn−/− mice die shortly after birth.
Surviving mice have 10–20% growth retardation and exhibit some skeletal abnormalities such as shorter subchondral bone, weaker ligaments, and moderate scoliosis (Cai
et al. unpublished data), which complicate mechanistic exploration in a specific tissue, cartilage, for example. Thus, in
future studies, we will disable Postn in a temporal (inducible) and cartilage-specific manner by genetic ablation in
mature mice to study OA development.
This study has some limitations, we did not report data
from heterozygotes (Postn+/−) since no protective effect
was observed in those mice. Other limitations included
the lack of measurement of functional outcomes such as
behavior, pain, and gait as well as the lack of assessment
of progressive changes as the only one-time point was
studied in both models. Moreover, detailed analysis of
osteophyte structure and histology is lacking. Another
limiting factor was also difficulty to breed and raise Postn
homozygous mice due to post-natal death of mice. Due to
limiting number of mice available “sham” procedure could
not be performed and could be a superior control for this
model. Lastly, as we performed bulk RNA-seq only on primary chondrocytes, the findings should be interpreted
within the context of cartilage. Since OA is considered a
whole-joint disease and Postn plays a role in the bone and
probably other parts of the joint, the lack of data from
other tissue and cell types is a limitation.

Conclusions
In summary, Postn genetic loss-of-function protects against
DMM-induced post-traumatic and age-related spontaneous
OA. Our data identify Postn as a novel therapeutic target to
delay or prevent OA, independent of the cause despite
aforementioned limitations. Further mechanistic studies are
warranted to investigate the tissue-specific role(s) of Postn
in OA and its impact on other knee tissues such as meniscus and ligaments. Postn modulating therapies will have to
be identified and tested before these findings have translational value in the clinical setting.
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